GENETIC POLYMORPHISM OF CYP2B6 AFFECTS THE PHARMACOKINETICS OF SIBUITRAMINE'S METABOLITE

被引：0
|
作者：
Cho, M. S. [1 ]
Jang, S. [1 ]
Lee, Y. [1 ]
Lim, L. [1 ]
Park, K. [1 ]
Chung, J. [1 ]
机构：
[1] Yonsei Univ, Coll Med, Seoul, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [31] Prevalence of CYP2B6 polymorphisms in Argentinians: the role of genetic testing
    Scibona, P.
    Vazquez, C.
    Cajal, A. R.
    Argibay, P. F.
    Belloso, W. H.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04): : 16594 - 16599
  • [32] PharmVar GeneFocus: CYP2B6
    Desta, Zeruesenay
    El-Boraie, Ahmed
    Gong, Li
    Somogyi, Andrew A.
    Lauschke, Volker M.
    Dandara, Collet
    Klein, Kathrin
    Miller, Neil A.
    Klein, Teri E.
    Tyndale, Rachel F.
    Whirl-Carrillo, Michelle
    Gaedigk, Andrea
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (01) : 82 - 97
  • [33] Association of CYP2B6, CYP3A5, and CYP2C19 Genetic Polymorphisms With Sibutramine Pharmacokinetics in Healthy Korean Subjects
    Kim, K. A.
    Song, W. K.
    Park, J. Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (05) : 511 - 518
  • [34] Associations of CYP2B6 genetic polymorphisms with Hirschsprung's disease in a southern Chinese population
    Liu, Yanqing
    Lan, Chaoting
    Li, Bingxiao
    Wang, Ning
    Zuo, Xiaoyu
    Huang, Lihua
    Wu, Yuxin
    Zhu, Yun
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (12)
  • [35] Effects of the CYP2B6*6 Allele on Catalytic Properties and Inhibition of CYP2B6 In Vitro: Implication for the Mechanism of Reduced Efavirenz Metabolism and Other CYP2B6 Substrates In Vivo
    Xu, Cong
    Ogburn, Evan T.
    Guo, Yingying
    Desta, Zeruesenay
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (04) : 717 - 725
  • [36] Association between CYP2C19 and CYP2B6 phenotypes and the pharmacokinetics and safety of diazepam
    Zubiaur, Pablo
    Figueiredo-Tor, Laura
    Villapalos-Garcia, Gonzalo
    Soria-Chacartegui, Paula
    Navares-Gomez, Marcos
    Novalbos, Jesus
    Matas, Miriam
    Calleja, Sofia
    Mejia-Abril, Gina
    Roman, Manuel
    Ochoa, Dolores
    Abad-Santos, Francisco
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 155
  • [37] Effects of CYP2D6 genetic polymorphism on the pharmacokinetics of metoclopramide
    Jung-Woo Bae
    Kyung-Yul Oh
    So-Jung Yoon
    Hyo-Bin Shin
    Eui Hyun Jung
    Chang-Keun Cho
    Chang Woo Lim
    Pureum Kang
    Chang-Ik Choi
    Choon-Gon Jang
    Seok-Yong Lee
    Yun Jeong Lee
    Archives of Pharmacal Research, 2020, 43 : 1207 - 1213
  • [38] Effects of CYP2D6 genetic polymorphism on the pharmacokinetics of metoclopramide
    Bae, Jung-Woo
    Oh, Kyung-Yul
    Yoon, So-Jung
    Shin, Hyo-Bin
    Jung, Eui Hyun
    Cho, Chang-Keun
    Lim, Chang Woo
    Kang, Pureum
    Choi, Chang-Ik
    Jang, Choon-Gon
    Lee, Seok-Yong
    Lee, Yun Jeong
    ARCHIVES OF PHARMACAL RESEARCH, 2020, 43 (11) : 1207 - 1213
  • [39] CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children
    Saitoh, Akihiko
    Sarles, Elizabeth
    Capparelli, Edmund
    Aweeka, Francesca
    Kovacs, Andrea
    Burchett, Sandra K.
    Wiznia, Andrew
    Nachman, Sharon
    Fenton, Terence
    Spector, Stephen A.
    AIDS, 2007, 21 (16) : 2191 - 2199
  • [40] Effect of CYP2B6 Genotype on the Pharmacokinetics of Sibutramine and Active Metabolites in Healthy Subjects
    Chung, Jae Yong
    Jang, Seong Bok
    Lee, Yoon Jung
    Park, Min Soo
    Park, Kyungsoo
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (01): : 53 - 59
12345